5 Issues To Watch As Fed. Circ. Hears Moderna Vax IP Case
With $1.3 billion at stake, Arbutus Biopharma Corp. v. Moderna Inc. is this fall's main event at the U.S. Court of Appeals for the Federal Circuit, with expedited oral argument scheduled...To view the full article, register now.
Already a subscriber? Click here to view full article